Lipitor in Ireland, no luck here, either
On 10 July 2007, the Dublin High Court held that Ranbaxy’s product infringes the Pfizer Base patent.
Same result, different country (see the scorecard on this site for details). [Note, though that based on an appellate decision in late May, Ranbaxy can now launch in Norway.]
Appeals in this dispute are pending in a few jurisdictions at the moment.
It will be interesting to see who will launch next and when (of the very many other companies preparing to launch atorvastatin).